Table 1.
The characteristics of both FRDA and control cases used within this study
| Case | Pathological diagnosis | Sex (M/F) | Age (years) | Cause of death |
|---|---|---|---|---|
| 1 | FRDA | F | 33 | Heart Failure |
| 2 | FRDA | M | 46 | Pneumonia |
| 3 | FRDA | M | 50 | Pneumonia |
| 4 | FRDA/FRDA variant | F | 66 | Pneumonia |
| 5 | FRDA | F | 42 | Pneumonia |
| 6 | FRDA | M | 51 | Pulmonary Embolism |
| 7 | FRDA | M | 47 | Not known |
| 8 | FRDA | F | n/a | Not known |
| mean | 47.9 | |||
| SE | 4.5 | |||
| 1 | Control | M | 82 | Not known |
| 2 | Control | M | 88 | Prostate cancer, bone metastases |
| 3 | Control | M | 68 | Heart failure, fibrosing alveolitis, coronary artery artheroma |
| 4 | Control | M | 84 | Bladder cancer, pneumonia |
| 5 | Control | M | 82 | Myelodysplastic syndrome, rheumatoid arthritis |
| mean | 80.8 | |||
| SE | 3.4 |